THOMAS MCBRIDE: Open Payments
NPI 1174515209 · CANTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 36 payments from 13 companies in 2025. Trend: 2023 $43 · 2024 $185 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 5 | $254 |
| Dendreon Pharmaceuticals LLC | 4 | $127 |
| Janssen Biotech, Inc. | 3 | $109 |
| PFIZER INC. | 5 | $100 |
| Astellas Pharma US Inc | 4 | $82 |
| Telix Pharmaceuticals | 5 | $80 |
| Ferring Pharmaceuticals Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: XIAFLEX, XTANDI, PROVENGE, ILLUCCIX, RYBREVANT, ADSTILADRIN, AVEED, BOTOX.
Industry payments across NY — which companies pay providers there.
